US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist

2.0000
-0.0200-0.99%

Close May 16 16:00 ET

130.93MMarket Cap-1379P/E (TTM)

Regulus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-7.74%-8.74M

-4.87%-26.77M

2.05%-6.13M

6.77%-6.28M

-1.51%-6.25M

-27.16%-8.11M

-5.79%-25.53M

20.15%-6.25M

-21.05%-6.73M

-22.59%-6.16M

Net income from continuing operations

-18.63%-8.47M

-6.05%-30.04M

-18.63%-8.06M

-3.62%-7.82M

3.38%-7.01M

-6.25%-7.14M

-1.85%-28.32M

4.74%-6.8M

12.48%-7.55M

-20.29%-7.26M

Depreciation and amortization

68.75%81K

86.07%227K

130.30%76K

75.00%56K

51.61%47K

84.62%48K

-73.42%122K

-19.51%33K

-15.79%32K

-31.11%31K

Other non cash items

3.23%32K

6.02%141K

-12.50%28K

3.23%32K

56.25%50K

-18.42%31K

189.13%133K

357.14%32K

82.35%31K

166.67%32K

Change In working capital

-6.61%-1.5M

-53.27%257K

297.18%846K

25.76%537K

-55.66%282K

-93.94%-1.41M

-39.82%550K

115.03%213K

-80.63%427K

-26.13%636K

-Change in receivables

--0

----

-87.50%1K

50.00%-4K

----

106.50%8K

-Change in prepaid assets

-33.48%445K

856.72%507K

87.11%-112K

-7.45%-202K

-50.81%152K

-1.76%669K

-180.72%-67K

13.53%-869K

-134.69%-188K

62.63%309K

-Change in payables and accrued expense

103.34%20K

-247.88%-698K

-170.97%-252K

-25.71%234K

-159.42%-82K

-633.93%-598K

258.92%472K

94.81%-93K

-70.72%315K

-72.40%138K

-Change in other current liabilities

45.62%-149K

-1,290.00%-238K

-42.63%393K

-692.86%-83K

19.17%-274K

19.41%-274K

-72.60%20K

-14.59%685K

-86.92%14K

-37.25%-339K

-Change in other working capital

-51.29%-1.82M

448.80%686K

66.73%817K

104.55%585K

-6.73%485K

-2.56%-1.2M

-77.36%125K

-15.08%490K

0.35%286K

-3.88%520K

Cash from discontinued investing activities

Operating cash flow

-7.74%-8.74M

-4.87%-26.77M

2.05%-6.13M

6.77%-6.28M

-1.51%-6.25M

-27.16%-8.11M

-5.79%-25.53M

20.15%-6.25M

-21.05%-6.73M

-22.59%-6.16M

Investing cash flow

Cash flow from continuing investing activities

-623.66%-78.54M

195.84%14.49M

-52.88%4.93M

57.70%-5.44M

14,804.90%15M

-5,923.90%-15.12M

25,629.27%10.47M

-49,365.38%-12.86M

-9,536.64%-12.62M

Net PPE purchase and sale

-22,800.00%-229K

-68.98%-610K

-7.94%-68K

-17,933.33%-541K

--0

99.02%-1K

-43.82%-361K

-53.66%-63K

88.46%-3K

-47.33%-193K

Net investment purchase and sale

-622.10%-78.32M

202.32%15.1M

-52.52%5M

61.90%-4.9M

--0

--15M

---14.76M

--10.53M

---12.86M

---12.43M

Cash from discontinued investing activities

Investing cash flow

-623.66%-78.54M

195.84%14.49M

-52.88%4.93M

57.70%-5.44M

--0

14,804.90%15M

-5,923.90%-15.12M

25,629.27%10.47M

-49,365.38%-12.86M

-9,536.64%-12.62M

Financing cash flow

Cash flow from continuing financing activities

11,665.84%93.11M

163.10%11.82M

-873K

-93.61%287K

13.21M

-40,350.00%-805K

-91.64%4.49M

112,325.00%4.49M

Net issuance payments of debt

0.00%-826K

---3.3M

---826K

--0

Net common stock issuance

447,180.95%93.93M

236.67%15.12M

---47K

-75.21%1.11M

--14.03M

950.00%21K

-91.65%4.49M

--0

89,680.00%4.49M

--0

Proceeds from stock option exercised by employees

--2K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

11,665.84%93.11M

163.10%11.82M

---873K

-93.61%287K

--13.21M

-40,350.00%-805K

-91.64%4.49M

--0

112,325.00%4.49M

--0

Net cash flow

Beginning cash position

-1.90%23.83M

-59.81%24.29M

28.98%25.9M

6.09%37.33M

-43.72%30.37M

-59.81%24.29M

94.44%60.45M

-44.09%20.08M

-15.23%35.18M

70.45%53.96M

Current changes in cash

-4.29%5.82M

98.72%-461K

-149.03%-2.07M

24.33%-11.43M

137.03%6.96M

193.81%6.08M

-223.15%-36.16M

-82.82%4.21M

-170.12%-15.11M

-290.83%-18.78M

End cash Position

-2.38%29.65M

-1.90%23.83M

28.98%25.9M

6.09%37.33M

-43.72%30.37M

-59.81%24.29M

-44.09%20.08M

-15.23%35.18M

Free cash flow

-10.55%-8.97M

-5.77%-27.38M

1.90%-6.2M

-1.22%-6.82M

1.57%-6.25M

-25.17%-8.12M

-6.19%-25.89M

19.77%-6.32M

-20.54%-6.74M

-23.22%-6.35M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-7.74%-8.74M	-4.87%-26.77M	2.05%-6.13M	6.77%-6.28M	-1.51%-6.25M	-27.16%-8.11M	-5.79%-25.53M	20.15%-6.25M	-21.05%-6.73M	-22.59%-6.16M
Net income from continuing operations	-18.63%-8.47M	-6.05%-30.04M	-18.63%-8.06M	-3.62%-7.82M	3.38%-7.01M	-6.25%-7.14M	-1.85%-28.32M	4.74%-6.8M	12.48%-7.55M	-20.29%-7.26M
Depreciation and amortization	68.75%81K	86.07%227K	130.30%76K	75.00%56K	51.61%47K	84.62%48K	-73.42%122K	-19.51%33K	-15.79%32K	-31.11%31K
Other non cash items	3.23%32K	6.02%141K	-12.50%28K	3.23%32K	56.25%50K	-18.42%31K	189.13%133K	357.14%32K	82.35%31K	166.67%32K
Change In working capital	-6.61%-1.5M	-53.27%257K	297.18%846K	25.76%537K	-55.66%282K	-93.94%-1.41M	-39.82%550K	115.03%213K	-80.63%427K	-26.13%636K
-Change in receivables	--0	----	----	----	-87.50%1K	50.00%-4K	----	----	----	106.50%8K
-Change in prepaid assets	-33.48%445K	856.72%507K	87.11%-112K	-7.45%-202K	-50.81%152K	-1.76%669K	-180.72%-67K	13.53%-869K	-134.69%-188K	62.63%309K
-Change in payables and accrued expense	103.34%20K	-247.88%-698K	-170.97%-252K	-25.71%234K	-159.42%-82K	-633.93%-598K	258.92%472K	94.81%-93K	-70.72%315K	-72.40%138K
-Change in other current liabilities	45.62%-149K	-1,290.00%-238K	-42.63%393K	-692.86%-83K	19.17%-274K	19.41%-274K	-72.60%20K	-14.59%685K	-86.92%14K	-37.25%-339K
-Change in other working capital	-51.29%-1.82M	448.80%686K	66.73%817K	104.55%585K	-6.73%485K	-2.56%-1.2M	-77.36%125K	-15.08%490K	0.35%286K	-3.88%520K
Cash from discontinued investing activities
Operating cash flow	-7.74%-8.74M	-4.87%-26.77M	2.05%-6.13M	6.77%-6.28M	-1.51%-6.25M	-27.16%-8.11M	-5.79%-25.53M	20.15%-6.25M	-21.05%-6.73M	-22.59%-6.16M
Investing cash flow
Cash flow from continuing investing activities	-623.66%-78.54M	195.84%14.49M	-52.88%4.93M	57.70%-5.44M	0	14,804.90%15M	-5,923.90%-15.12M	25,629.27%10.47M	-49,365.38%-12.86M	-9,536.64%-12.62M
Net PPE purchase and sale	-22,800.00%-229K	-68.98%-610K	-7.94%-68K	-17,933.33%-541K	--0	99.02%-1K	-43.82%-361K	-53.66%-63K	88.46%-3K	-47.33%-193K
Net investment purchase and sale	-622.10%-78.32M	202.32%15.1M	-52.52%5M	61.90%-4.9M	--0	--15M	---14.76M	--10.53M	---12.86M	---12.43M
Cash from discontinued investing activities
Investing cash flow	-623.66%-78.54M	195.84%14.49M	-52.88%4.93M	57.70%-5.44M	--0	14,804.90%15M	-5,923.90%-15.12M	25,629.27%10.47M	-49,365.38%-12.86M	-9,536.64%-12.62M
Financing cash flow
Cash flow from continuing financing activities	11,665.84%93.11M	163.10%11.82M	-873K	-93.61%287K	13.21M	-40,350.00%-805K	-91.64%4.49M	0	112,325.00%4.49M	0
Net issuance payments of debt	0.00%-826K	---3.3M	---826K	---826K	---826K	---826K	--0	--0	--0	--0
Net common stock issuance	447,180.95%93.93M	236.67%15.12M	---47K	-75.21%1.11M	--14.03M	950.00%21K	-91.65%4.49M	--0	89,680.00%4.49M	--0
Proceeds from stock option exercised by employees	--2K	----	----	----	----	--0	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	11,665.84%93.11M	163.10%11.82M	---873K	-93.61%287K	--13.21M	-40,350.00%-805K	-91.64%4.49M	--0	112,325.00%4.49M	--0
Net cash flow
Beginning cash position	-1.90%23.83M	-59.81%24.29M	28.98%25.9M	6.09%37.33M	-43.72%30.37M	-59.81%24.29M	94.44%60.45M	-44.09%20.08M	-15.23%35.18M	70.45%53.96M
Current changes in cash	-4.29%5.82M	98.72%-461K	-149.03%-2.07M	24.33%-11.43M	137.03%6.96M	193.81%6.08M	-223.15%-36.16M	-82.82%4.21M	-170.12%-15.11M	-290.83%-18.78M
End cash Position	-2.38%29.65M	-1.90%23.83M	-1.90%23.83M	28.98%25.9M	6.09%37.33M	-43.72%30.37M	-59.81%24.29M	-59.81%24.29M	-44.09%20.08M	-15.23%35.18M
Free cash flow	-10.55%-8.97M	-5.77%-27.38M	1.90%-6.2M	-1.22%-6.82M	1.57%-6.25M	-25.17%-8.12M	-6.19%-25.89M	19.77%-6.32M	-20.54%-6.74M	-23.22%-6.35M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall